Smoking status over two years in patients with multiple sclerosis

Neuroepidemiology

Volumn 32, Issue 1, 2008, Pages 72-79

  Marrie, Ruth Ann ^a,d   Cutter, Gary ^b   Tyry, Tuula ^c   Campagnolo, Denise ^c   Vollmer, Timothy ^c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c BARROW NEUROLOGICAL INSTITUTE   (United States)

^d HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Depression; Multiple sclerosis; Self reported smoking status; Smoking; Social class; Test retest reliability validity

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM; CIGARETTE SMOKING; CORRELATION COEFFICIENT; DEPRESSION; FEMALE; HUMAN; KAPPA STATISTICS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; QUESTIONNAIRE; SELF REPORT; SMOKING; SMOKING CESSATION; SOCIAL CLASS; SOCIAL STATUS; TEST RETEST RELIABILITY; VALIDITY;

ADOLESCENT; ADULT; FEMALE; HEALTH BEHAVIOR; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; QUESTIONNAIRES; REGISTRIES; SMOKING; SMOKING CESSATION; YOUNG ADULT;

EID: 55549092428     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000170910     Document Type: Article

References (39)

1. Illing EMM, Kaiserman MJ: Mortality attributable to tobacco use in Canada and its regions, 1998. Can J Public Health 2004;95:38-44.
2. Surgeon General: The health consequences of smoking: a report of the Surgeon General. Washington, Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004.
3. Riise T, Nortvedt MW, Ascherio A: Smoking is a risk factor for multiple sclerosis. Neurology 2003;61:1122-1124.
4. Hernan MA, Jick SS, Logroscino G, Olek MJ, Ascherio A, Jick H: Cigarette smoking and the progression of multiple sclerosis. Brain 2005;128:1461-1465.
5. Sabbagh MN, Tyas SL, Emery SC, Hansen LA, Alford MF, Reid RT, et al: Smoking affects the phenotype of Alzheimer disease. Neurology 2005;64:1301-1303.
6. Scott WK, Zhang F, Stajich JM, Scott BL, Stacy MA, Vance JM: Family-based case-control study of cigarette smoking and Parkinson disease. Neurology 2005;64:442-447.
7. Bowlin SJ, Morrill BD, Nafziger AN, Lewis C, Pearson TA: Reliability and changes in validity of self-reported cardiovascular disease risk factors using dual response: the behavioral risk factor survey. J Clin Epidemiol 1996;49:511-517.
8. Stein AD, Lederman RI, Shea S: The Behavioral Risk Factor Surveillance System questionnaire: its reliability in a statewide sample. Am J Public Health 1993;83:1768-1772.
9. Huerta M, Chodick G, Balicer RD, Davidovitch N, Grotto I: Reliability of self-reported smoking history and age at initial tobacco use. Prev Med 2005;41:646-650.
10. Seymour DG, Ball AE, Russell EM, Primrose WR, Garratt AM, Crawford JR: Problems in using health survey questionnaires in older patients with physical disabilities. The reliability and validity of the SF-36 and the effect of cognitive impairment. J Eval Clin Pract 2001;7:411-418.
11. Maor Y, Olmer L, Mozes B: The relation between objective and subjective impairment in cognitive function among multiple sclerosis patients - the role of depression. Mult Scler 2001;7:131-135.
12. Compston A, Coles A: Multiple sclerosis. Lancet 2002;359:1221-1231.
13. Consortium of Multiple Sclerosis Centers. NARCOMS Multiple Sclerosis. http://www.mscare.org/cmsc/CMSC-NARCOMS-Information.html (accessed 01/05/2008).
14. Marrie RA, Cutter G, Tyry T, Campagnolo D, Vollmer T: Validation of the NARCOMS Registry: diagnosis. Mult Scler 2007;13:770-775.
15. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, US Department of Health and Human Services, 1995.
16. Marrie RA, Cutter G, Tyry T, Vollmer T, Campagnolo D: Does multiple sclerosis-associated disability differ between races? Neurology 2006;66:1235-1240.
17. Hohol MJ, Orav EJ, Weiner HL: Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult Scler 1999;5:349-354.
18. Weissman MM, Sholomskas D, Pottenger M, Prusoff BA, Locke BZ: Assessing depressive symptoms in five psychiatric populations: a validation study. Am J Epidemiol 1977;106:203-214.
19. Unutzer J, Patrick DL, Marmon T, Simon GE, Katon WJ: Depressive symptoms and mortality in a prospective study of 2,558 older adults. Am J Geriatr Psychiatry 2002;10:521-530.
20. Pandya R, Metz L, Patten SB: Predictive value of the CES-D in detecting depression among candidates for disease-modifying multiple sclerosis treatment. Psychosomatics 2005;46:131-134.
21. Hosmer DW, Lemeshow S: Applied Logistic Regression. New York, Wiley, 1989.
22. Collins JG: Prevalence of selected chronic conditions, United States, 1986-88. National Center for Health Statistics. Vital Health Stat 10 1993, pp 1-87.
23. Jacobs LD, Wende KE, Brownscheidle CM, Apatoff B, Coyle PK, Goodman A, et al: A profile of multiple sclerosis: the New York State Multiple Sclerosis Consortium. Mult Scler 1999;5:369-376.
24. Centers for Disease Control and Prevention. Summary Health Statistics for U.S. Adults: National Health Interview Survey, 2004. Hyattsville, National Center for Health Statistics, 2006.
25. Turner AP, Kivlahan DR, Kazis LE, Haselkorn JK: Smoking among veterans with multiple sclerosis: prevalence correlates, quit attempts, and unmet need for services. Arch Phys Med Rehabil 2007;88:1394-1399.
26. Nortvedt MW, Riise T, Maeland JG: Multiple sclerosis and lifestyle factors: the Hordaland Health Study. Neurol Sci 2005;26:334-339.
27. Pekmezovic T, Drulovic J, Milenkovic M, Jarebinski M, Stojsavljevic N, Mesaros S, et al: Lifestyle factors and multiple sclerosis: a case-control study in Belgrade. Neuroepidemiology 2006;27:212-216.
28. Di Pauli F, Reindl M, Ehling R, Schautzer F, Gneiss C, Lutterotti A, et al: Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Mult Scler 2008;14:1026-1030.
29. Marrie RA, Horwitz RI, Cutter G, Tyry T, Campagnolo D, Vollmer T: Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology, in press.
30. Koch M, van Harten A, Uyttenboogaart M, De Keyser J: Cigarette smoking and progression in multiple sclerosis. Neurology 2007;69:1515-1520.
31. De Reuck J, De Weweire M, Van Maele G, Santens P: Comparison of age of onset and development of motor complications between smokers and non-smokers in Parkinson's disease. J Neurol Sci 2005;231:35-39.
32. Brownson RC, Eyler AA, King AC, Shyu Y-L, Brown DR, Homan SM: Reliability of information on physical activity and other chronic disease risk factors among US women aged 40 years or older. Am J Epidemiol 1999;149:379-391.
33. Eppel A, O'Loughlin J, Paradis G, Platt R: Reliability of self-reports of cigarette use in novice smokers. Addict Behav 2006;31:1700-1704.
34. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW: Can comorbidity be measured by questionnaire rather than medical record review? Med Care 1996;34:73-84.
35. Klabunde CN, Reeve BB, Harlan LC, Davis WW, Potosky AL: Do patients consistently report comorbid conditions over time? Results from the prostate cancer outcomes study. Med Care 2005;43:391-400.
36. Stanton CA, Papandonatos G, Lloyd-Richardson EE, Niaura R: Consistency of self-reported smoking over a 6-year interval from adolescence to young adulthood. Addiction 2007;102:1831-1839.
37. Kenney BA, Holahan CJ: Depressive symptoms and cigarette smoking in a college sample. J Am Coll Health 2008;56:409-414.
38. Wilhelm K, Wedgwood L, Niven H, Kay-Lambkin F: Smoking cessation and depression: current knowledge and future directions. Drug Alcohol Rev 2006;25:97-107.
39. Marrie RA, Cutter G, Tyry T, Vollmer T, Campagnolo D: Disparities in the management of multiple sclerosis-related bladder symptoms. Neurology 2007;68:1971-1978.